In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.
|Videos|September 26, 2016
Meena Moran on Nurses and Nurse Navigators as Part of Multidisciplinary Care
Author(s)Meena Moran, MD
Meena Moran discusses the importance of nurses and nurse navigators when treating patients with cancer through a multidisciplinary approach.
Advertisement
Meena Moran, MD, from the Smilow Cancer Hospital at Yale-New Haven highlights the importance of nurses and nurse navigators as part of multidisciplinary care.
It is the nurses who form a strong connection and provide support for patients. This connection is vital when gathering information that contributes to a patient’s decision making. Nurse navigators also support the patient and reinforce recommendations from oncologists.
Advertisement
Related to this article
Interviews with 15 young women with breast cancer show fertility preservation decisions unfold under time pressure and carry into survivorship.
Lisa Carter-Bawa, PhD, MPH, APRN, explains how nurses can counter lung cancer fatalism by pairing honesty with hope and using teach-back.
Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.
As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Care Coordination Faces Neoadjuvant Chemotherapy Delays in MIBC
2
Outpatient Tarlatamab Feasible in Community Oncology, Real-World Data Show
3
Teaching Communication as a Clinical Skill for Breast Cancer Care
4
FDA Approves Amivantamab for Recurrent or Metastatic HNSCC
5